Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MGK_2's Profile
Displaying 751-800 of 888 result(s).
CYDY CytoDyn Inc
06/02/2022 11:49:16 AM
The only way I see Amarex getting o (2)
CYDY CytoDyn Inc
06/02/2022 11:34:46 AM
I know that LL is a CCR5 blockade. (1)
CYDY CytoDyn Inc
06/02/2022 9:52:03 AM
some of the paper's findings: Leron (3)
CYDY CytoDyn Inc
06/02/2022 9:05:22 AM
here it is in Frontiers: https://ww
CYDY CytoDyn Inc
06/02/2022 8:14:19 AM
I have felt for a long time that th
CYDY CytoDyn Inc
06/02/2022 8:00:40 AM
and that's why CytoDyn remains in h (4)
CYDY CytoDyn Inc
06/01/2022 11:05:59 PM
no clue who JLang is, so had to loo (1)
CYDY CytoDyn Inc
06/01/2022 7:48:28 PM
Chemokines exist in the body at low (1)
CYDY CytoDyn Inc
06/01/2022 6:05:15 PM
not that I'm aware of either. is it
CYDY CytoDyn Inc
06/01/2022 5:50:08 PM
Given that this is arbitration, I t (1)
CYDY CytoDyn Inc
06/01/2022 5:32:18 PM
So as per Otto Yang, the immune sys
CYDY CytoDyn Inc
06/01/2022 3:35:51 PM
I agree with you. I don't know why (1)
CYDY CytoDyn Inc
06/01/2022 1:34:09 PM
Interferon alpha is an upregulator
CYDY CytoDyn Inc
06/01/2022 1:13:00 PM
These 3 recent deals, the 2 private (1)
CYDY CytoDyn Inc
06/01/2022 11:58:55 AM
We do know the identity of one of t (1)
CYDY CytoDyn Inc
06/01/2022 11:09:11 AM
Could management themselves be crea
CYDY CytoDyn Inc
06/01/2022 9:13:32 AM
i don't follow this side of things
CYDY CytoDyn Inc
06/01/2022 7:40:57 AM
In the last conference call, at abo (4)
CYDY CytoDyn Inc
06/01/2022 7:33:20 AM
That alone should have spoke volume (1)
CYDY CytoDyn Inc
05/31/2022 10:15:05 PM
Yes Figgs, The question that requir (1)
CYDY CytoDyn Inc
05/31/2022 9:03:04 PM
Going back to this study: https://w (3)
CYDY CytoDyn Inc
05/31/2022 7:29:51 PM
I was so used to Reddit for so long
CYDY CytoDyn Inc
05/31/2022 6:17:12 PM
Got a question on the relationship (3)
CYDY CytoDyn Inc
05/31/2022 5:48:33 PM
To me, I find it kind of repulsive (2)
CYDY CytoDyn Inc
05/31/2022 1:32:58 PM
I do not know Pestells cost basis o (1)
CYDY CytoDyn Inc
05/31/2022 12:44:13 PM
Thanks Ken for clarifying which was
CYDY CytoDyn Inc
05/31/2022 11:30:48 AM
My thought here is that CytoDyn mgt (1)
CYDY CytoDyn Inc
05/31/2022 9:42:17 AM
Thanks z_smith. That's revealing th (2)
CYDY CytoDyn Inc
05/31/2022 7:30:10 AM
The way I see it is, that the only (6)
CYDY CytoDyn Inc
05/30/2022 8:19:39 PM
***My Opinion*** Medicine today is (9)
CYDY CytoDyn Inc
05/30/2022 7:08:11 PM
When it comes to overall survivabil (1)
CYDY CytoDyn Inc
05/30/2022 6:02:09 PM
Well, here we have a woman, damn ne (2)
CYDY CytoDyn Inc
05/30/2022 4:30:19 PM
Thanks chuckles, So would this have
CYDY CytoDyn Inc
05/30/2022 3:36:52 PM
So then, are we to understand that (1)
CYDY CytoDyn Inc
05/30/2022 1:41:49 PM
I wasn’t invested at the time, bu (1)
CYDY CytoDyn Inc
05/29/2022 9:47:43 PM
It is but a few days from now. We w (2)
CYDY CytoDyn Inc
05/29/2022 8:17:11 PM
OK, I took your positivity in discu (1)
CYDY CytoDyn Inc
05/29/2022 7:59:53 PM
Mic drop
CYDY CytoDyn Inc
05/29/2022 4:41:45 PM
I’ll take that as an affirmative
CYDY CytoDyn Inc
05/29/2022 2:56:23 PM
Awesome, thank you for that breakdo (3)
CYDY CytoDyn Inc
05/29/2022 6:40:04 AM
So CytoDyn was basing its BTD for m (6)
CYDY CytoDyn Inc
05/29/2022 6:05:45 AM
Thank you chuckles. I appreciate ma (2)
CYDY CytoDyn Inc
05/28/2022 4:57:53 PM
We are discussing the following Poo
CYDY CytoDyn Inc
05/28/2022 2:26:08 PM
and to add to this, I feel Kelly wa (3)
CYDY CytoDyn Inc
05/28/2022 11:57:31 AM
Thanks Ken for taking this further. (4)
CYDY CytoDyn Inc
05/28/2022 11:24:54 AM
Thanks ohm. I'll take this a bit fu (3)
CYDY CytoDyn Inc
05/27/2022 9:59:22 PM
Not a bad friggin idea. These are s
CYDY CytoDyn Inc
05/27/2022 9:44:07 PM
We can't even say that we will defi (2)
CYDY CytoDyn Inc
05/27/2022 8:43:17 PM
Leronlimab does not dislodge chemok (2)
CYDY CytoDyn Inc
05/27/2022 6:42:48 AM
Ken, I appreciate the reply. In my (6)
Go to page:
  • << First
  • < Previous
  • 15
  • 16
  • Next >

Recent Articles

  • Michael Owen Partners with GK8 for iGaming Expansion Success
  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Niche Matters: How Focusing Drives RIA Growth and Client Loyalty
  • Significant Movement in Bitcoin as Long-Dormant Wallet Empties
  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site